First Trust Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.52M | Buy |
|
|||||
|
2025
Q1 | $3.64M | Sell |
|
|||||
|
2024
Q4 | $4.25M | Sell |
|
|||||
|
2024
Q3 | $4.51M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $718K | Sell |
|
|||||
|
2023
Q4 | $963K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.24M | Buy |
|
|||||
|
2023
Q1 | $1.36M | Sell |
|
|||||
|
2022
Q4 | $2.34M | Buy |
|
|||||
|
2022
Q3 | $1.58M | Sell |
|
|||||
|
2022
Q2 | $3.01M | Buy |
|
|||||
|
2022
Q1 | $2.85M | Sell |
|
|||||
|
2021
Q4 | $4.24M | Buy |
|
|||||
|
2021
Q3 | $3.54M | Sell |
|
|||||
|
2021
Q2 | $5.48M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $188K | Buy |
|